Anti-Inflammatory Actions of the Heme Oxygenase-1 Pathway
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2541-2551
Author(s):
M. J. Alcaraz, P. Fernandez and M. I. Guillen
Stem Cell Gene Therapy for Chronic Renal Failure
Journal:
Current Gene Therapy
Volume:
3
Page:
387-394
Author(s):
T. Yokoo, K. Sakurai, T. Ohashi and T. Kawamura
PPAR Ligands for Metabolic Disorders
Journal:
Current Topics in Medicinal Chemistry
Volume:
3
Page:
1649-1661
Author(s):
Garret J. Etgen and Nathan Mantlo
Role of Endothelin in Diabetic Retinopathy
Journal:
Current Vascular Pharmacology
Volume:
1
Page:
243-250
Author(s):
Hing-Chung Lam, Jenn-Kuen Lee, Chih-Chen Lu, Chih-Hsun Chu, Ming-Ju Chuang and Mei-Chun Wang
Vasomotor Effects of Iodinated Contrast Media: Just Side Effects?
Journal:
Current Vascular Pharmacology
Volume:
1
Page:
321-328
Author(s):
Ugo Limbruno and Raffaele De Caterina
Cardiovascular Diseases and the Nitric Oxide Pathway
Journal:
Current Vascular Pharmacology
Volume:
1
Page:
335-346
Author(s):
Silvia Llorens and Eduardo Nava
A Possible Target of Antioxidative Therapy for Diabetic Vascular Complications-Vascular NAD(P)H Oxidase
Journal:
Current Medicinal Chemistry
Volume:
10
Page:
1759-1764
Author(s):
T. Inoguchi, H. Tsubouchi, T. Etoh, M. Kakimoto, T. Sonta, H. Utsumi, H. Sumimoto, H. Y. Yu, N. Sonoda, M. Inuo, N. Sato, N. Sekiguchi, K. Kobayashi and H. Nawata
Novel Cardiovascular Risk Factors and Macrovascular and Microvascular Complications of Diabetes
Journal:
Current Drug Targets
Volume:
4
Page:
477-486
Author(s):
P. Theuma and V. A. Fonseca
Hypertension to Heart Failure: New Developmental Strategies do not Cross a Clinical and Therapeutic Divide
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1665-1678
Author(s):
Robert J. MacFadyen, Gregory Y.H. Lip and Russell Davis
Ethnicity and Drug Therapy for Hypertension
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1691-1701
Author(s):
K Amudha, Li P Wong, Anna-Maria J Choy and Chim C. Lang